Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Livzon Mabpharm
company
About
Livzon Mabpharm is a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.
- 501 - 1000
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2010
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Livzon Mabpharm has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jun 27, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 27, 2018 | Series A | — | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
1
Livzon Mabpharm has made 1 investments. Their most recent investment was on
Apr 16, 2014, when Epirus Biopharmaceuticals raised $36M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 16, 2014
Epirus Biopharmaceuticals
|
Series B | $36M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
